Procter & Gamble’s third-quarter fiscal performance for 2024 showed a modest 1% YoY increase in net sales to $20.2 billion, slightly below Wall Street’s expectations. However, diluted earnings per share grew by 11% to $1.52, surpassing analysts’ forecasts of $1.42. While the beauty segment saw 3% organic sales growth, sales in the Greater China region declined by 10%, mainly attributed to a significant 30% drop in SK-II sales. Despite this, there are signs of monthly improvement in Greater China’s overall sales, with an estimated one to two quarters for full growth recovery.